As Bernie Focuses On Older Drug-Device Combos, Can Innovators Catch Their Breath?

 
• By Sarah Karlin-Smith
  
bernie and inhalers
AstraZeneca, GSK, Boehringer Ingelheim and Teva are targets of latest Senate Dems drug pricing investigation • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America